Sol-Gel Technologies Ltd.

The momentum for this stock is not very good. Sol-Gel Technologies Ltd. is not a good growth stock. Sol-Gel Technologies Ltd. is a mediocre stock to choose.

Sol-Gel Technologies Ltd. is a clinical-stage dermatology company, which focuses on identifying, dev...

News

Sol-Gel Technologies (NASDAQ:SLGL) Trading Down 14.7%

Zolmax Shares of Sol-Gel Technologies Ltd. (NASDAQ:SLGL - Get Free Report) traded down 14.7% during trading on Monday . The stock traded as low as $0.54 and last traded at $0.58. 180,167 shares traded hands...\n more…

Sol-Gel Technologies (NASDAQ:SLGL) Stock Price Down 14.7%

Ticker Report Shares of Sol-Gel Technologies Ltd. (NASDAQ:SLGL - Get Free Report) were down 14.7% during trading on Monday . The stock traded as low as $0.54 and last traded at $0.58. Approximately 180,167 shares...\n more…

All You Need to Know About SolGel Technologies (SLGL) Rating Upgrade to Strong Buy

Zacks Investment Research Sol-Gel Technologies Ltd. (SLGL) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #1 (Strong Buy). An upward trend in earnings estimates -- one of the most...\n more…

Sol-Gel Technologies (NASDAQ:SLGL) Downgraded by Raymond James to "Outperform"

Ticker Report Raymond James cut shares of Sol-Gel Technologies (NASDAQ:SLGL - Free Report) from a strong-buy rating to an outperform rating in a report issued on Monday, Marketbeat.com reports. The brokerage...\n more…

Sol-Gel Technologies (NASDAQ:SLGL) Announces Quarterly Earnings Results

Zolmax Sol-Gel Technologies (NASDAQ:SLGL - Get Free Report) issued its quarterly earnings results on Friday. The company reported $0.07 EPS for the quarter, topping the consensus estimate of ($0.20) by...\n more…

Sol-Gel Technologies (NASDAQ:SLGL) Posts Earnings Results

Zolmax Sol-Gel Technologies (NASDAQ:SLGL - Get Free Report) posted its quarterly earnings data on Friday. The company reported $0.07 EPS for the quarter, topping the consensus estimate of ($0.20) by $0.27...\n more…